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Abstract
Whole genome approaches using single nucleotide polymorphism (SNP) markers have the
potential to transform complex disease genetics and expedite pharmacogenetics research.
This has led to a requirement for high-throughput SNP genotyping platforms.
Development of a successful high-throughput genotyping platform depends on coupling
reliable assay chemistry with an appropriate detection system to maximise efﬁciency with
respect to accuracy, speed and cost. Current technology platforms are able to deliver
throughputs in excess of 100 000 genotypes per day, with an accuracy of >99%, at a cost
of 20–30 cents per genotype. In order to meet the demands of the coming years, however,
genotyping platforms need to deliver throughputs in the order of one million genotypes per
day at a cost of only a few cents per genotype. In addition, DNA template requirements
must be minimised such that hundreds of thousands of SNPs can be interrogated using a
relatively small amount of genomic DNA. As such, it is predicted that the next generation
of high-throughput genotyping platforms will exploit large-scale multiplex reactions and
solid phase assay detection systems. Copyright # 2001 John Wiley & Sons, Ltd.
Keywords: SNP; genotyping technology; genetic variation; sequence detection; SNP
detection; allelic discrimination; high-throughput
Introduction
Single nucleotide polymorphisms (SNPs) have
gained wide acceptance as genetic markers for use
in linkage and association studies. The SNP Con-
sortium (TSC) and others have mapped >1.4
million SNP markers and placed this information
within the public domain [34]. It has been estimated
that, with the advent of a linkage disequilibrium
(LD) map, around 100 000 SNP markers will be
needed to carry out a whole genome association
(WGA) study [21]. WGA approaches, which
involve large-scale SNP genotyping, are expected
to transform complex disease genetics and realise
the potential of pharmacogenetics. To achieve this,
very high-throughput SNP genotyping platforms
are required.
The pharmaceutical industry, biotechnology com-
panies and academic groups alike, aspire to carry
out an increasing volume of SNP genotyping with-
out increasing the cost of genetics research. To meet
this demand, the search is on to ﬁnd a genotyping
technology able to deliver accurate genotyping at
very high throughput and at low cost per genotype.
In addition, the desired platform should be simple,
reliable and ﬂexible with respect to assay design and
development. Current technologies can deliver
>99% accuracy, at a rate of >100 K genotypes
per day, at a cost of around 20–30 cents per
genotype. Whilst this is a vast improvement on
what was possible one to two years ago, we now
seek a platform able to deliver >99% accuracy, at a
rate of >1 million genotypes per day, costing a few
cents per genotype. At the same time we wish to
minimise DNA usage to around 1ng per genotype,
or less.
In this review we discuss: those chemistries most
suitable for high-throughput SNP genotyping;
detection systems for high-throughput analysis of
assay products; commercial platforms most suited
to the high-throughput arena; and future trends in
high-throughout genotyping technologies.
In addition to chemistry and detection prefer-
ences, it is important to consider how the output
data of the preferred platform(s) will be interpreted.
To achieve high-throughput genotyping, allele
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Many technology providers favour automated allele
calling systems which score conﬁdence in the
automatic call, requiring user intervention only
where the score is lower than a predetermined
threshold. Sample tracking and data management
are also important considerations for high-
throughput genotyping laboratories making some
form of Laboratory Information Management
System (LIMS) an essential component of any
genotyping facility.
High-throughput assay chemistry
There are a host of chemistries available for allelic
discrimination, some more suitable for high-
throughput SNP genotyping than others. Broadly
speaking, methods are based on one or more of the
following molecular mechanisms: 1. allele speciﬁc
hybridisation; 2. ﬂap endonuclease discrimination;
3. primer extension; 4. allele speciﬁc digestion; or 5.
oligonucleotide ligation. In addition to being
accurate and reliable, the chemistry needs to be
inexpensive, readily amenable to automation and
simple with respect to assay design and develop-
ment.
1. Allele speciﬁc hybridisation (ASH)
The 5k nuclease or TaqMan assay [25], dynamic
allele speciﬁc hybridisation (DASH) [15], molecular
beacons [40] and the scorpions assay [44] are all
examples of ASH SNP genotyping technologies
with high-throughput potential. Of these, TaqMan
(Applied Biosystems,[proof note: URL to go on the
next line] http://www.appliedbiosystems.com) has
recently been adapted for high-throughput applica-
tion [32]. Allelic discrimination depends on two
allele speciﬁc probes, labelled with a probe-speciﬁc
ﬂuorescent dye and a generic quencher that reduces
ﬂuorescence in the intact probe. During ampliﬁca-
tion of the sequence surrounding the SNP, probes
complimentary to the DNA target are cleaved by
the 5kexonuclease activity of Taq polymerase (Fig-
ure 1a). Spatial separation of the dye and quencher
results in an increase in probe-speciﬁc ﬂuorescence,
detectable using a plate reader.
Recent advances in TaqMan chemistry include
the launch of a 384-well version of the platform, the
use of a dark (non-ﬂuorescent) quencher, and minor
groove binder probes which allow the probe length
to be shorter for improved allelic discrimination. In
addition, an assay design and manufacture service
(Assays-by-Design) is now offered by Applied
Biosystems to facilitate the development of success-
ful assays.
2. Flap endonuclease discrimination
The Invader assay (Third Wave Technologies Inc,
http://www.twt.com) involves nuclease cleavage of a
signal probe when two overlapping oligonucleotides
hybridise to a complimentary DNA target. A
generic invader probe and an allele speciﬁc primary
probe are simultaneously hybridised to the target
sequence such that they overlap at the site of a SNP
when the primary probe is complimentary to the
target. The triplex structure that results is recog-
nised and cleaved by a ﬂap endonuclease, releasing
a probe speciﬁc tail sequence or ‘ﬂap’ (Figure 1b).
The cleaved fragment may be labelled with a probe
speciﬁc ﬂuorescent dye, which ﬂuoresces following
probe cleavage due to spatial separation from a
quencher. Alternatively, the ﬂap may act as the
invader probe in a secondary reaction to amplify
ﬂuorescent signal (Invader squared) [12].
Recent modiﬁcations to the published method
have increased applicability of this technology for
high-throughput genotyping. PCR amplicons can
be used as the DNA template for Invader reactions
to reduce the requirement for DNA [28]. Further-
more, large multiplex (100-plex) PCR reactions
have been shown to further reduce DNA require-
ments, minimise the cost implications of using
PCR as a template and increase throughput of this
platform [31]. Recently, it has been demonstrated
that Invader reactions can be carried out in solid
phase using oligonucleotide-bound streptavidin-
coated particles [45]. This may provide a very
high-throughput genotyping platform that requires
a very small amount of DNA per genotype.
3. Primer extension
Primer extension, also known as mini-sequencing,
forms the basis of a number of methods for allelic
discrimination. An extension primer is annealed 5k
to a SNP, either adjacent to but not including the
SNP or several bases upstream of the SNP. The
primer is then extended for one or several nucleo-
tides to include the SNP site. In the case of
single base extension (SBE), a primer is annealed
adjacent to a SNP and extended to incorporate a
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Copyright # 2001 John Wiley & Sons, Ltd. Comp Funct Genom 2002; 3: 57–66.Figure 1. Allelic discrimination for a C/T SNP using ﬁve molecular mechanisms. a) TaqMan – the complimentary probe is
cleaved during PCR to release probe-speciﬁc ﬂuorescence. b) Invader squared – the triplex structure (circled), formed
between the target sequence, invader probe and primary probe, is cleaved by a ﬂap endonuclease. c) Single base extension –
ﬂuorescently labelled ddNTPs are incorporated into an extension primer in an allele dependent manner. d) SNaPIT – a
diagnostic PCR primer is annealed close to the SNP and dUTP is incorporated in place of dTTP. UDG digestion results in
different length fragments representing the different alleles. e) OLA – A ﬂuorescently labelled allele-speciﬁc probe is
hybridised to the target DNA and ligated to a generic biotin-labelled probe
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(Figure 1c). SNaPshot (Applied Biosystems) involves
differential ﬂuorescent labelling of the four ddNTPs
in a SBE reaction allowing ﬂuorescent detection
of the incorporated nucleotide. SNP-IT (Orchid
Biosciences, http://www.orchidbio.com) is also based
on ﬂuorescent SBE and uses solid phase capture
and detection of extension products. A further
variant of primer extension is the Good assay
[37],38] which involves extension of a primer
modiﬁed near the 3k end with a charged tag to
increase sensitivity to mass spectrometry detection.
Following extension with a-S-(d)dNTPs, the unmod-
iﬁed 5k end of the primer is digested leaving a short
charged fragment suitable for high-throughput
mass spectrometry analysis [37].
Alternatives to SBE include Pyrosequencing [1],
allele speciﬁc primer extension (ASPE) and the
ampliﬁcation refractory mutation system (ARMS).
Pyrosequencing involves sequential addition of
dNTPs to an extension reaction. Incorporation of
a nucleotide triggers an enzymatic cascade that
releases a light signal, detected by a CCD camera.
Liquid handling and detection has been automated
in 384-well format for high-throughput genotyping.
Allele speciﬁc primer extension (ASPE) and the
ampliﬁcation refractory mutation system (ARMS)
are based on the same principle, namely that under
optimised conditions, a primer will only be
extended if the 3k nucleotide is complimentary to
the target sequence. These methods have recently
been coupled to high-throughput detection systems,
for example the Masscode system for mass spectro-
metry analysis of allele speciﬁc amplicons [18] and
capture of ASPE products onto beads for detection
by ﬂow cytometry [46].
4. Allele speciﬁc digestion
Restriction fragment length polymorphism (RFLP)
assays have been used extensively in the past to
genotype SNPs but are less amenable to automation
than many other methods. However, SNaPIT, an
alternative method of allele speciﬁc digestion of
PCR products, uses a generic approach that has
potential for high-throughput genotyping [42]. The
SNP and surrounding sequence is ampliﬁed in the
presence of a modiﬁed dNTP, for example dUTP,
using a diagnostic primer close to the SNP in either
the forward or reverse direction. Subsequent diges-
tion of the PCR product with a DNA glycosylase,
for example uracil-DNA-glycosylase (UDG), results
in different size fragments corresponding to the
different alleles [41] (Figure 1d). The diagnostic
primer can either be ﬂuorescently labelled to
enable separation and detection of the fragments
using a capillary sequencer or unlabelled for mass
spectrometry analysis. Assays are designed to
maximise multiplexing potential.
5. Oligonucleotide ligation
The oligonucleotide ligation assay (OLA) was ﬁrst
described for allelic discrimination by Landegren
et al. in 1988 [22] and has since been modiﬁed to
exploit a themostable DNA Ligase [3]; interogate
PCR templates [29]; and utilise a dual-colour
detection system [35]. OLA involves ligation of
two oligonucleotides, hybridised to a DNA tem-
plate, one of which is allele speciﬁc such that it will
only form part of a ligated product if it is
complimentary to the target sequence (Figure 1e).
OLA gave rise to another technique, Padlock [30],
which involves circularisation of allele speciﬁc
probes and it is Padlock that forms the basis of
the rolling circle ampliﬁcation (RCA) high-
throughput genotyping technology [10]. Following
circularisation of an allele speciﬁc open circle probe
(OCP), exponential ampliﬁcation is achieved using
two primers. One of the primers is speciﬁc to the
OCP backbone and is ﬂuorescently labelled to
distinguish between the allele speciﬁc OCPs. In
addition, the labelled primer contains a hairpin loop
and a quencher such that ﬂuorescence is suppressed
until the primer forms a double stranded molecule
with the circularised probe. This disrupts the hair-
pin loop, separating the ﬂuorophore and quencher
and results in a detectable increase in ﬂuorescent
signal.
Detection systems
Fluorescence is the most widely applied detection
method currently employed for high-throughput
genotyping. This is due to the ready availability of
suitable ﬂuorescent dyes and the diversity of their
application. The use of ﬂuorescence has been
teamed with a number of different detection sys-
tems including plate readers, capillary electro-
phoresis andDNA arrays. In addition to ﬂuorescence
detection, mass spectrometry and light detection
represent novel application of established tech-
nology for high-throughput genotyping.
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There are many ﬂuorescent plate readers capable of
detecting ﬂuorescence in a 96- or 384-well format
and some of these are detailed in Table 1. Most
models use a white light source and narrow band-
pass ﬁlters to select the excitation and emission
wavelengths and enable semi-quantitative steady
state ﬂuorescence intensity readings to be made.
This technology has been applied to genotyping
with TaqMan [32], Invader [13],31],28] and Rolling
Circle Ampliﬁcation [33],10]. Plate processing times
are sufﬁciently fast to enable one instrument to read
up to thirty 384-well plates per hour (over 10 000
determinations). This means that a single plate
reader can measure ﬂuorescence at the reaction end-
point for >100 000 reactions per day. Several
readers are available which combine a PCR block
with a ﬂuorescence detection system to enable the
user to monitor real-time changes in ﬂuorescence
throughout the course of the PCR (see Table 1).
These readers are primarily used for quantitative
RT-PCR but have also been applied to genotyping,
mainly in the clinical ﬁeld [14]. However, real-time
analysis is inevitably slower than end-point reading
and therefore, unsuitable for high-throughput geno-
typing.
Fluorescence plate readers are also available
which will allow measurement of additional ﬂuor-
escence parameters including polarisation, lifetime
and time resolved ﬂuorescence and ﬂuorescence
resonance energy transfer (see Table 1). Fluor-
escence polarisation has been applied to genotyping
using ARMS [11], Invader [16] and TaqMan [23].
Capillary electrophoresis
DNA capillary electrophoresis is a high-resolution
technique for the separation of DNA fragments
based on their size dependant mobility when
passing through a sieving matrix. Following separa-
tion, DNA fragments are analysed for ﬂuorescent
signal as well as fragment size. The development of
96 capillary electrophoresis sequencers has in-
creased the potential of this detection technique
for SNP genotyping.
Sanger sequencing is widely used in SNP dis-
covery and validation but its use in SNP genotyping
is limited by its low throughput and the relatively
high cost per sample. The development of sequenc-
ing technologies in microfabricated channels may
deliver signiﬁcantly reduced reagent costs and in-
creases throughputs by decreasing reaction volumes
and reducing run times [19],24],4],26],27]. Other
SNP genotyping methods such as SNaPshot, based
on SBE, and SNaPIT, based on allele speciﬁc
digestion, exploit ﬂuorescent sequencing detection
technology to achieve higher throughputs and lower
costs than sequencing through sample pooling and
the use of short run times [5],42].
DNA arrays
Oligonucleotide arrays, bound to a solid support,
have been proposed as the future detection platform
for high-throughput genotyping [36]. Two distinct
approaches have been adopted, involving ASH
whereby the oligonucleotide directly probes the
target and tag arrays that capture solution phase
Table 1. Fluorescent plate readers suitable for genotyping assay detection
Vendor Model Features
Applied Biosystems Cytoﬂuor 96 & 384 well plates
Applied Biosystems 7700 Laser excitation, CCD detection, realtime PCR applications, 96 well
Applied Biosystems 7900 Laser excitation, CCD detection, realtime PCR application, 384 well
Stratagene Mx4000 White light source, realtime PCR, 96 wells
Hybaid Chimera White light source, realtime PCR, 96 wells
APB FarCyte Up to 1536 wells. FI, FP, FRET, TRF, Luminescence
ThermoLabsystems Fluoroskan Ascent 96 & 384 well plates
Tecan Ultra Up to 1536 wells. FI, FP, TRF, luminescence and absorbance.
Tecan Polarion Xenon ﬂash lamp, up to 384 wells. FI, FP.
LJL Analyst, Acquest 96 & 384 well plates, FI, FP, TRF, TR-FRET, Luminescence and Epi-Absorbance.
CRI Afﬁnity Up to 1536 wells, FI, FP, FRET, Luminescence
Bio-Tek FL-600 Up to 384 wells, FI, Epiﬂuorescence, Luminescence, Absorbance
Wallac (Perkin Elmer) Viktor Up to 384 wells, FI, TRF, luminescence, absorbance
FI= Fluorescence intensity, FP=ﬂuorescence polarisation, FRET=Fluorescence Resonance Energy Transfer, TRF=Time Resolved Fluorescence,
TR-FRET=Time Resolved Fluorescence Resonance Energy Transfer
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sequences.
The HuSNP GeneChip (Affymetrix) contains
allele speciﬁc probes for nearly 1500 SNPs [43].
The regions surrounding the SNPs are ampliﬁed by
multiplex PCR and the amplicons are probed with
the ASH array. This method is efﬁcient for geno-
typing large numbers of SNPs for one to many
DNA samples. Perlegen (http://www.perlegen.com)
have exploited this approach and produced arrays
in collaboration with Affymetrix that will enable
them to perform genome wide SNP discovery and
genotyping at high-density. Luminex (http://www.
luminexcorp.com) have developed a panel of one
hundred bead sets with unique ﬂuorescent labels,
identiﬁable using a ﬂow analyser. The bead sets can
be derivitised with allele speciﬁc oligonucleotides to
create a bead-based array for multiplex genotyping
by ASH [2].
Tag arrays are generic assemblies of oligonucleo-
tides that are used to sort or deconvolute mixtures
of oligos by hybridisation to the anti-tag sequences
[6]. Affymetrix have produced the GenFlex array
with 2000 tag sequences that are used to analyse the
products of multiplex primer extension reactions [9].
Bead arrays have also been derivitised to form tag
arrays and their application has been demonstrated
in multiplex primer extension [8], rolling circle [20]
and OLA [17] genotyping assays. Illumina (http://
www.illumina.com) have produced a tag array where
beads are bound to the tips of a bundle of ﬁber
optic probes.
Mass spectrometry
Many genotyping techniques involve the allele
speciﬁc incorporation of two alternative nucleotides
into an oligonucleotide probe. Mass spectrometry
can be used to determine which variant nucleotide
has been incorporated by measuring the mass of the
products and this approach has been applied prima-
rily to genotyping by primer extension [7] using the
MALDI-TOF (Matrix Assisted Laser Desorption/
Ionization – Time of Flight Mass Spectrometry)
approach. There are many vendors of mass spectro-
meters including Agilent, Applied Biosystems,
Bruker, GenTech, Hitachi, JEOL, Kratos, LECO,
Micromass, Shimadzu, ThermoFinnigan, Varian
and Waters.
The polyanionic nature of oligonucleotides results
in low signal to noise, particularly for longer
(>40 mer) fragments. This has been addressed by
speciﬁcally cleaving long probes by acidolysis of
P3k–N5k phosphoramidate bonds [39] and by a
combined approach whereby the probe is digested
to a very short fragment which has been derivatised
to lower its charge to a single positive or negative
charge [37].
Light
Pyrosequencing involves hybridisation of a sequenc-
ing primer to a single stranded template and
sequential addition of individual dNTPs using a
dedicated instrument [1]. Incorporation of a dNTP
into a primer releases pyrophosphate that triggers a
luciferase-catalyzed reaction. The light produced is
detected by a charge coupled device (CCD) camera
and each light signal is proportional to the number
of nucleotides incorporated (http://www.pyrosequen-
cing.com). The Pyrosequencing platform exempliﬁes
novel application of existing technologies to
develop solutions for high-throughput genotyping.
Commercial platforms most suited to
the high-throughput arena
To achieve high-throughput genotyping, the chal-
lenge lies in pairing the right assay chemistry with
the right detection system to maximise efﬁciency
with respect to accuracy, speed and cost. Many
commercially available platforms have achieved this
very successfully and some of these are outlined in
Table 2. Platforms currently able to deliver >100
000 genotypes per instrument per day use ﬂuores-
cent plate readers for detection of SNP alleles.
However, such detection systems are less likely than
others, such as those based on DNA arrays, to
provide the basis of signal detection for the next
generation of genotyping platforms due to reagent
cost and DNA consumption considerations. As
illustrated in Table 2, no single genotyping chem-
istry is emerging as the method of choice, although
an increasing number of platforms employ primer
extension chemistries, due to the potential for
multiplexing.
Future trends in high-throughput
genotyping technologies
The next generation of high-throughput genotyping
platforms are likely to employ an extensive scale
of optimised multiplex reactions (y100-plex)
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extension currently forms the basis of many multi-
plex genotyping approaches (Table 2) and other
chemistries such as OLA have considerable multi-
plex potential. In addition, any genotyping chem-
istry that can be developed for solid phase
multiplexing, as demonstrated for the Invader
technology [45], may spur future genotyping plat-
forms. High-density DNA chips for analysis of
extensive multiplex reactions may be based on the
Affymetrix HuSNP (ASH) or GenFlex (tag) chips;
bead arrays such as the Luminex bead system; or
miniaturised bead arrays bound to Illumina’s ﬁbre
optic bundles. Solid phase multiplex approaches
will not only increase throughputs and drive down
costs but will also reduce the amount of DNA
required per genotype, making whole genome
association studies feasible with limited DNA
resources.
A number of technology providers such as
Caliper (http://www.calipertech.com) and ACLARA
Biosciences (http://www.aclara.com) are exploiting
the use of microchannels as a way to miniaturise
assay chemistry and detection. Both the LabChip
2
system (Caliper) and LabCard (ACLARA Bio-
sciences) offer automated SNP interrogation using
very small volumes in microchannel networks.
Minaturisation of genotyping reactions offers a
reduction in both reagent cost and DNA require-
ments, whilst the level of automation facilitates high
throughput of reactions.
Many technology providers are now developing
SNP panels for whole genome linkage and associa-
tion. This will make it possible to buy off-the-shelf
assay panels at reduced cost compared with custom
synthesis. For some platforms, such as those
involving ASH DNA chips, the SNP panel is ﬁxed,
while for others, the use of a genome wide panel
may be an option, with ﬂexibility for custom syn-
thesis where needed. The development of genome
wide SNP panels, particularly when LD patterns
have been characterised across the genome, will
expedite the application of SNP genotyping for
genome wide linkage and association studies.
As an alternative to high-throughput genotyping,
a number of approaches have emerged for rapid
identiﬁcation of SNP allele frequency variation in
different populations, such as disease affected and
unaffected populations. For example, the LYNX
Megatype technology (http://www.lynxgen.com)
claims to compare the genomes of two populations
in a single experiment. The technology is based on
isolation of DNA fragments containing SNPs which
differ in allele frequency between populations. In
addition, a number of SNP genotyping tech-
nologies, including Pyrosequencing, appear to be
suitable for allele quantiﬁcation in pooled DNA
samples. It remains to be seen whether such
technologies will offer the sensitivity needed to
detect small differences in allele frequency (<5%)
between population speciﬁc pools of samples.
Conclusion
Homogeneous chemistries coupled with ﬂuorescent
plate reader detection currently offer the simplest
route to developing a high-throughput genotyping
platform. However, expensive reagent costs and
relatively high DNA template requirements mean
that miniaturisation of such methods will be
necessary to meet future demands. An alternative
is provided by the mass spectrometry platforms
where the key advantage is the use of mass
determination alone for allelic discrimination,
removing the need for expensive primer labelling.
Multiplex SNP genotyping strategies based on
DNA arrays offer considerable potential for the
next generation of platforms. The use of ASH
arrays with ﬁxed panels of SNPs may be a popular
option for genome wide studies while greater
ﬂexibility can be offered using tag arrays. The
laboratory processes associated with array detection
are readily amenable to automation for very high-
throughput genotyping.
It is likely that a well-positioned genotyping
laboratory will need to be equipped with more
than one platform to meet the demands of the
coming years. This is because the most efﬁcient and
cost effective technologies for very high-throughput
genotyping using genome-wide panels of SNP
markers may not necessarily be suitable for high-
density SNP analysis of smaller linked or associated
regions. It remains to be seen which genotyping
technology platforms will expedite genetics research
in the Pharmacogenetics and Pharmacogenomics
era.
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